Lucid Diagnostics Inc.
NASDAQ:LUCDMedical - Devices
+$0.04 today
- Market cap
- $79.38M
- Beta
- 1.08
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$0.44
Volume 2.70M
Average 0.84M
LUCD Total Liabilities
Everything the company owes to creditors and other parties.
Lucid Diagnostics Inc.NASDAQ: LUCD
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities falls 21.2% from a year ago
Total liabilities stood at $30.08M at the end of Q1 FY2026, down 21.2% from a year earlier and up 1.9% from the prior quarter. Over 3 fiscal years it compounded at +46.1% a year.
Context
- Total liabilities amounted to 88.3% of total assets at the end of Q1 FY2026, down 28.1 pp from a year earlier.
- Total liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -21.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 29.51M USD
- Year-over-year change
- +16.5%
- 4-year CAGR
- +62.2%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 29.51M | +16.5% |
| FY2024 | 2024-12-31 | 25.32M | -14.4% |
| FY2023 | 2023-12-31 | 29.58M | +212.6% |
| FY2022 | 2022-12-31 | 9.46M | +122.1% |
| FY2021 | 2021-12-31 | 4.26M | — |
Total Liabilities vs competitors
How LUCD compares with its peers on the latest reported figures
- LUCD's Mar 2026 total liabilities of $30.08M is the 8th highest of the 10 companies compared; the peer median is $49.94M.
- Its year-over-year change of -21.2% is the 9th highest of 10, against a peer median of +0.9%.
- Total liabilities amounts to 88.3% of total assets for LUCD, versus a peer median of 67.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $547.71M | +88.6% | +125.5% | 186.5% | |
IRDOpus Genetics, Inc. | Mar 2026 | $112.62M | +161.3% | +133.2% | 168.6% |
| Mar 2026 | $74.71M | +0.8% | +75.5% | 144.9% | |
| Mar 2026 | $50.91M | -19.7% | -9.9% | 58.7% | |
| Mar 2026 | $49.94M | +0.9% | +54.9% | 79.2% | |
| Mar 2026 | $41.97M | +110.4% | +16.3% | 67.3% | |
| Mar 2026 | $30.65M | -15.5% | -3.5% | 11.3% | |
| Mar 2026 | $30.08M | -21.2% | +46.1% | 88.3% | |
AVRAnteris Technologies Global Corp. | Mar 2026 | $16.31M | +4.0% | +49.5% | 5.5% |
| Mar 2026 | $2.22M | -74.7% | +28.8% | 1.2% | |
| Peer median (excluding LUCD) | $49.94M | +0.9% | +49.5% | 67.3% | |
Competitors are the stored peer set for LUCD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 53.66M | 22.47M | 18.9M | 22.36M | 34.71M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 200K | 17K | 45K | 405K | 643K |
| Inventory | 493K | 111K | 278K | 341K | 353K |
| Other Current Assets | 0 | 0 | 1.98M | 0 | 0 |
| Total Current Assets | 57.3M | 24.36M | 22.07M | 25.15M | 37.47M |
| Property, Plant & Equipment (Net) | 971K | 3.6M | 2.64M | 3.7M | 2.62M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 3.45M | 1.42M | 736K | 315K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 725K | 1.11M | 1.13M | 1.13M | 47K |
| Total Non-current Assets | 1.7M | 8.15M | 5.2M | 5.57M | 2.98M |
| Total Assets | 59M | 32.51M | 27.27M | 30.72M | 40.45M |
| Account Payables | 1.49M | 1.06M | 1.15M | 1.24M | 970K |
| Short-term Debt | 0 | 0 | 13.95M | 18.6M | 24M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 936K | 0 | 0 |
| Other Current Liabilities | 557K | 5.53M | 791K | 1.35M | 2.04M |
| Total Current Liabilities | 4.26M | 8.43M | 29.38M | 23.52M | 28.58M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 1.04M | 199K | 1.8M | 927K |
| Total Liabilities | 4.26M | 9.46M | 29.58M | 25.32M | 29.51M |
| Common Stock | 35K | 41K | 42K | 63K | 131K |
| Retained Earnings | (41.9M) | (98.08M) | (150.74M) | (203.77M) | (274.34M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 54.74M | 23.05M | (2.31M) | 5.39M | 10.94M |
| Total Debt | 0 | 2M | 15.26M | 21.25M | 25.82M |
| Net Debt | (53.66M) | (20.48M) | (3.64M) | (1.1M) | (8.89M) |
Lucid Diagnostics Inc.
NASDAQ:LUCD
Intrinsic Alpha fair value
Locked
Current Price
$0.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.